Related Experiment Video
Updated: Oct 3, 2025

08:20
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
11.4K
Female Adult Acne and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee
Enrico Carmina1, Brigitte Dreno2, W Anne Lucky3
1Endocrinology Unit, University of Palermo Medical School, Palermo, 90139, Italy.
Journal of the Endocrine Society
|February 14, 2022
Summary
Adult female acne management requires considering both dermatological and endocrine perspectives. Guidelines recommend androgen level assessment and specific hormonal therapies for hyperandrogenic acne.
Area of Science:
- Endocrinology
- Dermatology
- Reproductive Endocrinology
Background:
- Adult female acne is viewed differently in endocrine vs. dermatological literature.
- Polycystic Ovary Syndrome (PCOS) guidelines often link acne to androgen excess.
- Dermatological societies have developed new guidelines for adult female acne.
Observation:
- An expert task force convened to assess current knowledge on adult female acne.
- Recommendations were developed for specialists treating female adult acne.
- Evidence-based guidelines were established.
Findings:
- Clinical diagnosis is primary for adult female acne, but grading tools are needed.
- Serum androgen measurements are recommended for all adult acne patients.
- Oral estroprogestins are advised for acne with proven hyperandrogenism, alongside other treatments.
Implications:
- Second- and third-generation estroprogestins are suitable, regardless of dose or progestin type.
- Spironolactone can be added to estroprogestins for moderate-to-severe hyperandrogenic acne unresponsive to standard care.
- Estroprogestins serve as a second-line therapy for nonhyperandrogenic adult acne.
Related Concept Videos
Disorders of the Female Reproductive System
1.5K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
1.5K
Adrenal Gland Disorders
1.9K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.9K
Hormonal Regulation of the Menstrual Cycle
770
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
770
Menopause
1.2K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
1.2K
Oogenesis
64.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.7K
Hormonal Control of the Ovarian Cycle
4.0K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
4.0K

